Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
Contact us
Advanced
Homepage > Company > Media > Pharma News

Pharma News

BridgeBio Pharma nabs $750M in non-dilutive debt financing
BridgeBio Pharma nabs $750M in non-dilutive debt financing
BridgeBio Pharma executed a definitive credit facility agreement with a syndicate of lenders for up to $750M in financing which replaces its $100M debt facility with Hercules.
Pfizer, US ink $5.29B deal for possible COVID-19 treatment
Pfizer, US ink $5.29B deal for possible COVID-19 treatment
The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation's largest purchase agreement yet...
Moderna seeks FDA approval to authorize booster shots for all adults
Moderna seeks FDA approval to authorize booster shots for all adults
Moderna filed an application Wednesday with the Food and Drug Administration seeking emergency use authorization of vaccine booster shots for all Americans ages 18 and up. ...
LOKELMA® granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic hemodialysis with hyperkalemia
LOKELMA® granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic hemodialysis with hyperkalemia
AstraZeneca has been granted Fast Track Designation in the United States (US) for the development of LOKELMA® (sodium zirconium cyclosilicate) to reduce arrhythmia-related cardiovascular outcomes ...
Blood biomarker identified that predicts type 2 diabetes many years before diagnosis
Blood biomarker identified that predicts type 2 diabetes many years before diagnosis

An AI-based diagnostic tool is being developed through a biotech startup.

Cellectar’s Iopofosine I-131 Exhibits Signals of Efficacy in Phase I Study for Pediatric Brain and Solid Tumors
Cellectar’s Iopofosine I-131 Exhibits Signals of Efficacy in Phase I Study for Pediatric Brain and Solid Tumors
Cellectar Biosciences, Inc., a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announc...
Pfizer Asks FDA to Clear Covid Pill for High-Risk Patients
Pfizer Asks FDA to Clear Covid Pill for High-Risk Patients
Pfizer Inc. asked U.S. regulators for emergency-use authorization of its Covid-19 pill that could play a critical role in further protecting high-risk patients from the disease’s worst effects. ...
Rice lab first to mimic molecule found in poppies. Undergraduate leads synthesis of scarce extract, possible drug precursor
Rice lab first to mimic molecule found in poppies. Undergraduate leads synthesis of scarce extract, possible drug precursor
A Rice University undergraduate student’s grit and talent paid off in a big way when she introduced the first synthesis of a rare and potentially potent molecule drawn from poppies.  ...
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with uncontrolled epilepsy in England and Wales. ...
FDA Accepts Investigational New Drug Application and Grants Fast Track Designation of Trehalose for Spinocerebellar Ataxia Treatment
FDA Accepts Investigational New Drug Application and Grants Fast Track Designation of Trehalose for Spinocerebellar Ataxia Treatment
The Food and Drug Administration (FDA) has accepted the investigational new drug (IND) application to trehalose (SLS-005; Seelos Therapeutics, New York, NY) for spinocerebellar ataxia (SCA) treatme...
FDA Approves Treatment for Rare Blood Disease. Treatment is First FDA-Approved Option Patients Can Take Regardless of Previous Therapies
FDA Approves Treatment for Rare Blood Disease. Treatment is First FDA-Approved Option Patients Can Take Regardless of Previous Therapies
Today, the U.S. Food and Drug Administration approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red...
Pfizer CEO calls those spreading vaccine misinformation 'criminals'
Pfizer CEO calls those spreading vaccine misinformation 'criminals'

"They have literally cost millions of lives,” Albert Bourla said in an interview with the Atlantic Council.

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Inhibitors and approved drugs
Natural base
Virtual space
Drug Discovery Services
AI Kinome Profile
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept